United Financial Planning Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.5K Buy
+450
New +$67.5K 0.04% 88
2026
Q1
– Sell
-473
Closed -$65.2K – 567
2025
Q4
$65.2K Buy
473
+23
+5% +$3.01K 0.04% 82
2025
Q3
$57.7K Buy
+450
New +$54.9K 0.04% 76

Other funds holding NVS

United Financial Planning Group's NVS Position: Q2 2026 in Review

United Financial Planning Group opened a new position in Novartis (NVS) in Q2 2026: 450 shares worth $70.5K. The stake represents 0.04% of the portfolio and ranks #88 among its holdings. This is a return to the name: United Financial Planning Group previously reported a position in NVS as recently as Q4 2025.

United Financial Planning Group first reported a position in NVS in Q3 2025 and has held it in 3 quarters since. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • United Financial Planning Group held 450 shares of Novartis worth $70.5K as of Q2 2026.
  • Novartis was a new United Financial Planning Group position in Q2 2026.
  • Novartis made up 0.04% of United Financial Planning Group's portfolio in Q2 2026, its #88 holding.
  • United Financial Planning Group first reported a position in Novartis in Q3 2025 and has held it in 3 quarters since.
  • 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on United Financial Planning Group's 13F filing for Q2 2026, filed 6 Aug 2026.